Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
NMD Pharma A/S
A/S
Active
Reklamebeskyttelse
CVR 36899069
Palle Juul-Jensens Boulevard 82, 8200
Aarhus N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 11 years old
58 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NMD Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-3M
-5M
-8M
-10M
-11M
2021
-9M
2022
-19M
2023
-28M
2024
-26M
2025
EBITDA
DKK millions
0M
-11M
-21M
-32M
-43M
-14M
2021
-13M
+7%
2022
-23M
-77%
2023
-34M
-48%
2024
-34M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-11.029
-9.480
-19.182
-27.874
-26.063
Staff expenses
-3.224
-3.500
-4.040
-5.943
-7.966
EBITDA
-14.253
-12.980
-23.222
-33.817
-34.029
Depreciation & amort.
-0
-0
-19
-36
-54
EBIT
-14.253
-12.980
-23.241
-33.853
-34.083
Net financials
-98
-80
103
863
361
Profit before tax
-14.351
-13.061
-23.138
-32.990
-33.722
Tax
-737
-737
-737
-737
-737
Net profit
-13.614
-12.324
-22.401
-32.254
-32.985
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
4.920
27.139
46.393
39.394
23.005
Equity
2.596
25.133
42.673
35.395
12.410
Long-term debt
201
0
0
0
7.003
Short-term debt
2.123
2.006
3.720
3.999
3.591
Total debt
2.324
2.006
3.720
3.999
10.595
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-3402886500.0%
This company
2021
2025
Soliditetsgrad
53.9%
This company
38.2%
Market median
+41% vs market
2021
2025
Egenkapitalforrentning
-265.8%
This company
18.4%
Market median
-1545% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-3298537000.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
-1.13×
This company
2021
2025
Gæld/egenkapital
0.85×
This company
0.62×
Market median
+37% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on NMD Pharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
